Invention Grant
- Patent Title: Hepatitis C virus inhibitors
- Patent Title (中): 丙型肝炎病毒抑制剂
-
Application No.: US14477594Application Date: 2014-09-04
-
Publication No.: US09227940B2Publication Date: 2016-01-05
- Inventor: Alan Xiangdong Wang , Li-Qiang Sun , Sing-Yuen Sit , Ny Sin , Paul Michael Scola , Yan Chen
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo
- Main IPC: C07D207/16
- IPC: C07D207/16 ; A61K31/40 ; C07D217/24 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D413/14 ; C07D417/14 ; C07D491/04 ; C07K5/062 ; C07K5/083 ; C07K5/08 ; A61K45/06 ; A61K38/00
Abstract:
Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R′, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Public/Granted literature
- US20150005342A1 Hepatitis C Virus Inhibitors Public/Granted day:2015-01-01
Information query
